antianxiety drug - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 7533

<< First< Prev

Page of 377

Next >Last >>

Select item 14050821.

Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.

M Swartz, R Landerman, L K George, M L Melville, D Blazer, K Smith

Am J Public Health. 1991 May; 81(5): 592–596. doi: 10.2105/ajph.81.5.592

PMCID:: PMC1405082

Summary Page Browse PDF–3.2M

Select item 65644562.

Dopamine receptor antagonism by the novel antianxiety drug, buspirone

BA McMillen, RT Matthews, MK Sanghera, PD Shepard, DC German

J Neurosci. 1983 Apr 1; 3(4): 733–738. doi: 10.1523/JNEUROSCI.03-04-00733.1983

PMCID:: PMC6564456

Abstract PDF–814K

Select item 15751653.

Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand

Atsuko Kita, Hitoshi Kohayakawa, Tomoko Kinoshita, Yoshiaki Ochi, Keiko Nakamichi, Satoshi Kurumiya, Kiyoshi Furukawa, Makoto Oka

Br J Pharmacol. 2004 Aug; 142(7): 1059–1072. Published online 2004 Jul 12. doi: 10.1038/sj.bjp.0705681

PMCID:: PMC1575165

Article PDF–404K

Select item 16671794.

Alterations in brain 5-hydroxy-tryptamine metabolism during the `withdrawal' phase after chronic treatment with diazepam and bromazepam

R.A. Agarwal, Y.D. Lapierre, R.B. Rastogi, R.L. Singhal

Br J Pharmacol. 1977 May; 60(1): 3–9. doi: 10.1111/j.1476-5381.1977.tb16740.x

PMCID:: PMC1667179

Summary Page Browse PDF–1.0M

Select item 60846945.

Identification of Molecular Substrate for the Attenuation of Anxiety: A Step Toward the Development of Better Anti-Anxiety Drugs

Uwe Rudolph

ScientificWorldJournal. 2001; 1: 192–193. Published online 2001 May 1. doi: 10.1100/tsw.2001.33

PMCID:: PMC6084694

Abstract PDF–333K

Select item 77303306.

The GABA_A-Benzodiazepine Receptor Antagonist Flumazenil Abolishes the Anxiolytic Effects of the Active Constituents of Crocus sativus L. Crocins in Rats

Nikolaos Pitsikas, Petros A. Tarantilis

Molecules. 2020 Dec; 25(23): 5647. Published online 2020 Nov 30. doi: 10.3390/molecules25235647

PMCID:: PMC7730330

Article PDF–469K

Select item 64689817.

Treating pediatric anxiety: Initial use of SSRIs and other anti-anxiety prescription medications

Greta A. Bushnell, Scott N. Compton, Stacie B. Dusetzina, Bradley N. Gaynes, M. Alan Brookhart, John T. Walkup, Moira A. Rynn, Til Stürmer

J Clin Psychiatry. Author manuscript; available in PMC 2019 Apr 17.

Published in final edited form as: J Clin Psychiatry. 2018 Jan-Feb; 79(1): 16m11415. doi: 10.4088/JCP.16m11415

PMCID:: PMC6468981

Article PDF–188K

Select item 64815988.

Drug therapy for symptoms associated with anxiety in adult palliative care patients

Susan Salt, Caroline A Mulvaney, Nancy J Preston, Cochrane Pain, Palliative and Supportive Care Group

Cochrane Database Syst Rev. 2017 May; 2017(5): CD004596. Published online 2017 May 18. doi: 10.1002/14651858.CD004596.pub3

PMCID:: PMC6481598

Article PDF–378K

Select item 54872709.

Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents

Tingting Duan, Ning Gu, Ying Wang, Feng Wang, Jie Zhu, Yiru Fang, Yuan Shen, Jing Han, Xia Zhang

J Psychiatry Neurosci. 2017 Jul; 42(4): 230–241. Prepublished online 2016 Dec 13. doi: 10.1503/jpn.160116

PMCID:: PMC5487270

Article PDF–1.1M

Select item 391279110.

Anti-anxiety effect of a novel 5-HT₃ receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

Yeshwant Vijay Kurhe, Mahesh Radhakrishnan, Devadoss Thangaraj, Deepali Gupta

Indian J Pharmacol. 2014 Jan-Feb; 46(1): 100–104. doi: 10.4103/0253-7613.125186

PMCID:: PMC3912791

Article

Select item 498784211.

Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

Yijuan Du, Anthony A Grace

Neuropsychopharmacology. 2016 Sep; 41(10): 2455–2462. Prepublished online 2016 Mar 22. Published online 2016 Apr 13. doi: 10.1038/npp.2016.42

PMCID:: PMC4987842

Article PDF–352K

Select item 273737812.

Behavioral Health Services for Women Who Have Breast Cancer

Vanessa Azzone, Richard G. Frank, Juliana R. Pakes, Craig C. Earle, Michael J. Hassett

J Clin Oncol. 2009 Feb 10; 27(5): 706–712. Published online 2008 Dec 29. doi: 10.1200/JCO.2008.16.3006

PMCID:: PMC2737378

Article PDF–88K

Select item 825011313.

About anxiety levels and anti‐anxiety drugs among quarantined undergraduate Jordanian students during COVID‐19 pandemic

Abdelrahim Alqudah, Ahmad Al‐Smadi, Muna Oqal, Esam Y. Qnais, Mohammed Wedyan, Majd Abu Gneam, Roaa Alnajjar, Manar Alajarmeh, Elaf Yousef, Omar Gammoh

Int J Clin Pract. 2021 Jul; 75(7): e14249. Published online 2021 Apr 29. doi: 10.1111/ijcp.14249

PMCID:: PMC8250113

Article PDF–651K

Select item 414578514.

Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety

Ling Lan, Yu-Long Chen, Hao Zhang, Bai-Ling Jia, Yan-Jun Chu, Jin Wang, Shi-Xiao Tang, Guo-Dong Xia

World J Gastroenterol. 2014 Aug 28; 20(32): 11422–11428. Published online 2014 Aug 28. doi: 10.3748/wjg.v20.i32.11422

PMCID:: PMC4145785

Article PDF–1.0M

Select item 983075315.

Anxiolytic-like effect of Suanzaoren–Wuweizi herb-pair and evidence for the involvement of the monoaminergic system in mice based on network pharmacology

Jie Liu, Jin-Li Shi, Jian-You Guo, Yi Chen, Xiao-Jie Ma, Sheng-Nan Wang, Zhi-Quan Zheng, Ming-Xuan Lin, Shuai He

BMC Complement Med Ther. 2023; 23: 7. Published online 2023 Jan 9. doi: 10.1186/s12906-022-03829-1

PMCID:: PMC9830753

Article PDF–5.1M

Select item 142950416.

Pharmacology of anti-anxiety drugs with special reference to clobazam

Stuart Fielding, Irmgard Hoffmann

Br J Clin Pharmacol. 1979; 7(Suppl 1): 7S–14S.

PMCID:: PMC1429504

Summary Page Browse PDF–1.0M

Select item 188436017.

Evaluation of drug treatment in irritable bowel syndrome

Nicholas J Talley

Br J Clin Pharmacol. 2003 Oct; 56(4): 362–369. doi: 10.1046/j.1365-2125.2003.01966.x

Correction in:: Br J Clin Pharmacol. 2003 Nov; 56(5): 584.

PMCID:: PMC1884360

Article PDF–96K

Select item 455283318.

Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice

Li-Ping Yang, Fang-Jie Jiang, Gui-Sheng Wu, Ke Deng, Meng Wen, Xiaoju Zhou, Xuechuan Hong, Michael X. Zhu, Huai-Rong Luo

PLoS One. 2015; 10(8): e0136255. Published online 2015 Aug 28. doi: 10.1371/journal.pone.0136255

PMCID:: PMC4552833

Article PDF–1.1M

Select item 768574019.

dmPFC-vlPAG projection neurons contribute to pain threshold maintenance and antianxiety behaviors

Jun-Bin Yin, Shao-Hua Liang, Fei Li, Wen-Jun Zhao, Yang Bai, Yi Sun, Zhen-Yu Wu, Tan Ding, Yan Sun, Hai-Xia Liu, Ya-Cheng Lu, Ting Zhang, Jing Huang, Tao Chen, Hui Li, Zhou-Feng Chen, Jing Cao, Rui Ren, Ya-Nan Peng, Juan Yang, Wei-Dong Zang, Xiang Li, Yu-Lin Dong, Yun-Qing Li

J Clin Invest. 2020 Dec 1; 130(12): 6555–6570. Published online 2020 Nov 3. doi: 10.1172/JCI127607

PMCID:: PMC7685740

Article PDF–12M

Select item 422898420.

Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines

William R. Keller, Bernard A. Fischer, Robert McMahon, Walter Meyer, Melissa Blake, Robert W. Buchanan

J Nerv Ment Dis. Author manuscript; available in PMC 2015 Jan 1.

Published in final edited form as: J Nerv Ment Dis. 2014 Jan; 202(1): 6–12. doi: 10.1097/NMD.0000000000000093

PMCID:: PMC4228984

Article PDF–161K

<< First< Prev

Page of 377

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for antianxiety drug

Figure 1

Hydroxy buspirone (antianxiety drug): Enzymatic preparation of 6-hydroxybuspirone.

Biocatalytic Synthesis of Chiral Alcohols and Amino Acids for Development of Pharmaceuticals

Biomolecules. 2013 Dec;3(4):741-777.
Figure 2.

Compilation of studies on cannabis use and anxiety and prescription drug substitution. Ten cross-sectional analyses of cannabis use have been published. This graph displays the reported (top) anxiety benefits on behalf of the respondents and (bottom) reported substitution of antianxiety medications by cannabis users and respondents across these studies.

The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids

J Natl Cancer Inst Monogr. 2021 Dec;2021(58):86-98.
FIGURE 1

Percentage of interventions; note groups are listed by medication class and specification of a pharmacological class or individual drug was based on perceived importance of the distinction (antianxiety = non-benzodiazepine and non-antidepressants such as buspirone, gabapentin, and hydroxyzine; EPS = extrapyramidal symptoms; EtOH = ethanol; other sleep aids = amitriptyline, ramelteon, and trazodone)

Mental health pharmacists as interim prescribers

Ment Health Clin. 2017 May;7(3):111-115.
Figure 5

Disease-focused classification of fluoro-pharmaceuticals according to the Anatomical Therapeutic Chemical Classification (ATC) of the WHO. A: Gastrointestinal and metabolism action. B: Blood and hematopoietic organ. C: Circulatory system. D: Skin disease remedy. G: Urogenital system and sex hormone. H: General hormonal drug. J01: General antimicrobial. J02: General antifungal. J04: Antimycobacteria. J05: General antiviral. L01: Antitumor drug (molecularly targeted agents (MTAs)). L01: Antitumor drug (without MTAs). L04: Immunosuppressive agent. M01: Nonsteroidal anti-inflammatory drugs (NSAID). M09: Musculoskeletal system agents. N01: Anesthetics. N02: Antipyretic analgesics. N03: Antiepileptic drug. N04: Antiparkinson agent. N05A: Antipsychotic agent. N05B: Antianxiety agent. N05C: Hypnotic drug. N06: Antidepressant drug. N07: Nervous system agent. P: Anthelmintics. R: Respiratory disease agent. S: Sensory system disease agent. V: Others.

Contribution of Organofluorine Compounds to Pharmaceuticals

ACS Omega. 2020 May 19;5(19):10633-10640.